Modulating T cell responses for the treatment of psoriasis: a focus on efalizumab

Author： Cather Jennifer Clay   Cather J Christian   Menter Alan  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.3, Iss.2, 2003-04, pp. : 361-370

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective targeting of T cell subsets: focus on alefacept – a remittive therapy for psoriasis

By Krueger Gerald G  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 4, 2002-04 ,pp. : 431-441

Informa Healthcare

Access to resources Recommend Favorite

Efalizumab: continuous therapy for chronic psoriasis

By Cather Jennifer Clay   Menter Alan  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 3, 2005-03 ,pp. : 393-403

Informa Healthcare

Access to resources Recommend Favorite

Redirecting cytotoxic T lymphocyte responses with T-cell receptor transgenes

By Morse Michael   Lyerly H Kim   Clay Timothy M  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 4, 2002-04 ,pp. : 353-360

Informa Healthcare

Access to resources Recommend Favorite

Adoptive T-cell therapy for the treatment of solid tumours

By Knutson Keith L   Almand Bond   Mankoff David A   Schiffman Kathy   Disis Mary L  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 1, 2002-01 ,pp. : 55-66

Informa Healthcare

Access to resources Recommend Favorite

Viral vectors for inducing CD8+ T cell responses

By Truckenmiller Mary E   Norbury Christopher C  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 6, 2004-06 ,pp. : 861-868

Informa Healthcare

Access to resources Recommend Favorite